Asahi Kasei Corporation (AHKSF)
OTCMKTS
· Delayed Price · Currency is USD
6.12
-0.72 (-10.48%)
At close: Apr 8, 2025
Asahi Kasei Revenue
Asahi Kasei had revenue of 768.92B JPY in the quarter ending December 31, 2024, with 7.06% growth. This brings the company's revenue in the last twelve months to 2.98T, up 8.35% year-over-year. In the fiscal year ending March 31, 2024, Asahi Kasei had annual revenue of 2.78T with 2.14% growth.
Revenue (ttm)
2,979.98B JPY
Revenue Growth
+8.35%
P/S Ratio
0.50
Revenue / Employee
60.45M JPY
Employees
49,295
Market Cap
9.50B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 2,784.88B | 58.39B | 2.14% |
Mar 31, 2023 | 2,726.49B | 265.17B | 10.77% |
Mar 31, 2022 | 2,461.32B | 355.27B | 16.87% |
Mar 31, 2021 | 2,106.05B | -45.60B | -2.12% |
Mar 31, 2020 | 2,151.65B | -18.76B | -0.86% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 268.05M |
Rubber Leaf | 6.93M |
Cardinal Ethanol, LLC | 350.34M |
Venator Materials | 1.56B |
Verde Resources | 216.80K |
Webco Industries | 575.71M |
Asahi Kasei News
- 11 days ago - Ken Shinomiya Becomes Leader of Asahi Kasei's Healthcare Sector - Business Wire
- 18 days ago - Asahi Kasei: Materials Business Could Be Challenged By Macro - Seeking Alpha
- 27 days ago - Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward - Business Wire
- 2 months ago - Asahi Kasei Holds Grand Opening Ceremony for Biogas Purification System at Sewage Treatment Plant in Japan - Business Wire
- 3 months ago - Asahi Kasei Receives Governmental Support to Expand Manufacturing Capacity for Green Hydrogen Production Equipment in Japan - Business Wire
- 5 months ago - Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody - Business Wire
- 5 months ago - Licensee of Asahi Kasei Technology Begins Commercial Production of High-Purity Carbonates Using CO2 as Main Feedstock in China - Business Wire
- 5 months ago - GC exits venture amid competition - Bangkok Post